Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Proton pump inhibitors (PPIs) are widely used for acid suppression in the treatment and prevention of many conditions including gastroesophageal reflux disease, gastric and duodenal ulcers, erosive esophagitis, H. pylori infection, and pathological hypersecretory conditions. Most PPIs are metabolize...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Pharmacol Ther
Main Authors: Lima, John J., Thomas, Cameron D., Barbarino, Julia, Desta, Zeruesenay, Van Driest, Sara L., El Rouby, Nihal, Johnson, Julie A., Cavallari, Larisa H., Shakhnovich, Valentina, Thacker, David L., Scott, Stuart A., Schwab, Matthias, Uppugunduri, Chakradhara Rao S, Formea, Christine M., Franciosi, James P., Sangkuhl, Katrin, Gaedigk, Andrea, Klein, Teri E., Gammal, Roseann S., Furuta, Takahisa
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7868475/
https://ncbi.nlm.nih.gov/pubmed/32770672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares